FontsA A
ContrastA A
Newsletter sign-up [mc4wp_form id="1441"]

Topic: Ethics of AI Lab

The Ethics of AI Lab spearheads research, brings experts together and provides knowledge with focus on ethical, societal and legal issues related to AI's use in biobanking and biomedical research.

Artificial Intelligence (AI) is one of the most significant and exciting developments of the present. It is also seen as a promising innovation in the medical field. The application of medical AI opens complex questions concerning, for instance, informed consent, biases, trustworthiness, responsibility, and liability, as well as risks associated with data privacy and protection.

Ethics of AI considers the ethical and societal implications of AI use and the potentially far-reaching consequences of AI in society – and in the field of medicine.

The mission of the Ethics of AI Lab in BBMRI is to provide reliable, feasible and practical knowledge on ethical and social/societal matters of AI related to biobanking and biomedical research for the immediate benefit of the community. In bringing together experts, building on state-of-the-art research and learning from best practices, the Lab produces in-depth research and develops practical guidance.

The Ethics of AI Lab uses reliable research to develop practical knowledge in


Ethics of AI in Imaging: ​ Ethical and Societal Implications. Speakers: Melanie Goisauf and Mónica Cano Abadía

AI applications in medicine are hoped to improve healthcare and advance health equity. While the technology carries the potential to improve health services, the ethical and societal implications need to be carefully considered to avoid harmful consequences for individuals and groups, especially for the most vulnerable. Cano Abadía and Goisauf problematise approaches such as ‘trustworthy AI’ and ‘explainable AI’ that shape the ethics discourse on AI. The webinar concludes with a reflection on the topics identified that shape the understanding of ‘Ethics of AI’ and the gaps in the discourse. 


Ethics of AI in Radiology: A Review of Ethical and Societal Implications. Melanie Goisauf and Mónica Cano Abadía

In this paper, Mónica Cano Abadía and Melanie Goisauf contribute to the discourse on the ethics of AI in radiology by reviewing the state-of-the-art literature and discussing the findings from a philosophical and social science perspective. Our analysis was guided by two key research questions: (1) What types of ethical issues are raised by the use of AI in medicine and biomedical research, and (2) how are these issues being tackled in radiology, especially in the case of breast cancer

Ethical layering in AI-driven polygenic risk scores—New complexities, new challenges

Some members of the Ethics of AI Lab (Kaya Akyüz, Mónica Cano Abadía, and Michaela Th. Mayrhofer) explore with other colleagues the ethical implications of the confluence of artificial intelligence with polygenic risk score applications in medicine.

You Can’t Have AI Both Ways: Balancing Health Data Privacy and Access Fairly

This paper argues that the “AI revolution” in healthcare can only realise its full potential if a fair, inclusive engagement process spells out the values underlying (trans) national data governance policies and their impact on AI development, and priorities are set accordingly. With the contribution of Michaela Th. Mayrhofer.




INTERVENE seeks to advance AI-facilitated analyses of complex medical data to develop genetic risk scores, which summarize the estimated effect of an individual’s genetic makeup on the risk of developing a particular disease.


EuCanImage will build a highly secure, federated and large-scale cancer imaging platform, with capabilities that will greatly enhance the potential of Artificial Intelligence in oncology. Watch the ELSI contribution to the EUCAN Image project.


The project aims to create a repository of digital copies of around 3 million slides covering a range of disease areas. This repository will then be used to develop artificial intelligence tools that could aid in the analysis of slides.


The entry was co-funded by EuCanImage, INTERVENE, and BIG PICTURE, projects that have received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952103, No 101016775, and form the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 945358. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA.


Ask our team a question

The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.